Citius Oncology Inc.CTORNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P36
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-11.48%
Q3 20254.72%
Q2 202533.81%
Q1 2025-16.83%
Q4 20244.11%
Q3 2024-44.07%
Q2 20241.34%
Q1 2024-2.36%
Q4 20239.13%
Q3 2023-95.22%
Q2 20237.25%
Q1 2023-63.05%
Q4 202276.96%
Q3 2022-222.67%
Q2 20220.00%